Amylyx Pharmaceuticals Earnings
NASDAQ: AMLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 28.14 0.00%
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.38
Amylyx Pharmaceuticals earnings summary
Amylyx Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.38. In its most recent report on Aug 6, 2026 (Q2 2026), AMLX posted EPS of $-0.39. Across the last 16 reports, AMLX shares moved an average of 6.7% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
AMLX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-0.39 | — | -5.2% |
| May 7, 2026 | — | $-0.37 | — | -9.8% |
| Mar 3, 2026 | — | $-0.28 | — | +1.0% |
| Nov 6, 2025 | — | $-0.37 | — | +3.1% |
| Aug 7, 2025 | — | $-0.46 | — | +4.7% |
| May 8, 2025 | — | $-0.42 | — | +5.0% |
| Mar 4, 2025 | — | $-0.54 | — | -6.3% |
| Nov 7, 2024 | — | $-1.07 | — | -29.0% |
| Aug 8, 2024 | — | $-1.07 | — | +12.4% |
| May 9, 2024 | — | $-1.75 | — | +4.3% |
| Feb 22, 2024 | — | $0.07 | — | +6.0% |
| Nov 9, 2023 | — | $0.30 | — | -3.3% |
| Aug 10, 2023 | — | $0.31 | — | -6.4% |
| May 11, 2023 | — | $0.02 | — | -3.5% |
| Mar 13, 2023 | — | $-0.61 | — | -5.1% |
| Nov 10, 2022 | — | $-0.92 | — | +2.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.